Dexcom Rival Fights Its Bid To Tweak Glucose Monitor Patent

By Jamie Lennox · February 28, 2024, 7:51 PM GMT

A Korean medical tech company has asked a London court to block Dexcom's bid to tweak its diabetes management patent to avoid losing protections should the court rule that it's invalid....

To view the full article, register now.
Try a seven day FREE Trial

Already a subscriber? Click here to login

Related Sections

Featured Stories

Lawyers Adapt To Crop Of New FDA Pilots No Photo Available

Yeji Jesse Lee

A slew of new FDA pilot programs is forcing life science attorneys to adjust to a new reality of programs that shed bureaucratic proce... (more story)

Health Hires: Goodwin Partner Joins Incyte, Gilead GC Exits No Photo Available

Gianna Ferrarin

Law360 Healthcare Authority looks at the week's most notable personnel changes in the healthcare and life sciences industries.

Defamation Litigation Roundup: FDA, Lively, Alexander Bros. No Photo Available

Theresa Schliep

In this month's review of defamation fights, Law360 highlights a pharmaceutical company's suit against a former U.S. Food and Drug Adm... (more story)